| PERIOD ENDING | 25-Oct-09 | 26-Jul-09 | 26-Apr-09 | 25-Jan-09 | | Total Revenue | 75,147 | 66,317 | 60,077 | 62,695 | | Cost of Revenue | 33,776 | 30,165 | 27,345 | 29,345 | | | Gross Profit | 41,371 | 36,152 | 32,732 | 33,350 | | | Operating Expenses | | Research Development | 9,862 | 11,195 | 10,085 | 9,771 | | Selling General and Administrative | 19,429 | 16,626 | 17,570 | 16,124 | | Non Recurring |
-
| (188) | 188 | 273 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,080 | 8,519 | 4,889 | 7,182 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 282 | 1,290 | 406 | | Earnings Before Interest And Taxes | 13,216 | 8,801 | 6,179 | 7,588 | | Interest Expense |
-
|
-
|
-
| 3 | | Income Before Tax | 13,216 | 8,801 | 6,179 | 7,585 | | Income Tax Expense | 34,103 | 1,380 | 1,236 | 1,314 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (20,887) | 7,421 | 4,943 | 6,271 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (20,887) | 7,421 | 4,943 | 6,271 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($20,887) | $7,421 | $4,943 | $6,271 |
|
0.14% Nasdaq 
Income Statement
